Cas No.: 2031154-77-3
PRODUCT INFORMATION
Description
LinTT1 (sequence: AKRGARST) is a tumor-penetrating peptide that targets the p32 receptor (C1QBP), which is upregulated in various cancer models, including peritoneal carcinoma. It is used as a research tool to functionalize nanocarriers, enabling the study of mitochondrial-targeted delivery. This peptide has been investigated for its role in preclinical models, focusing on its ability to home to p32-expressing cells.
Molecular Weight
917.03
Purity
> 95%
Formula
C₃₆H₆₈N₁₆O₁₂
Product Type
Targeting Peptide
Sequence
Ala-Lys-Arg-Gly-Ala-Arg-Ser-Thr-Ala
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
- Cyclic(YCDGFYACYMDV) Targeting Peptide (CAT#: OLY-1025-YS-6)
- Cyclo(RGDyK) TFA Targeting Peptide (CAT#: OLY-1025-YS-54)
- GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
- CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.